Federated Hermes’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Federated Hermes's BMY Position: Q2 2026 in Review
Federated Hermes increased its Bristol-Myers Squibb (BMY) stake by 310% in Q2 2026, buying an estimated $6.17M and bringing the position to 142,019 shares worth $8.18M. The position accounts for 0.01% of the portfolio, ranked #746.
Federated Hermes first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $505M in Q4 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Federated Hermes held 142,019 shares of Bristol-Myers Squibb worth $8.18M as of Q2 2026.
- Federated Hermes bought 107,387 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.17M.
- Bristol-Myers Squibb made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #746 holding.
- Federated Hermes first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Bristol-Myers Squibb position peaked at $505M in Q4 2024.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.